TTK Healthcare Limited (BOM:507747)

Market Cap	15.55B -7.3%
Revenue (ttm)	8.88B +8.3%
Net Income	739.60M +17.2%
EPS	52.34 +17.2%
Shares Out	14.13M
PE Ratio	21.03
Forward PE	n/a
Dividend	10.00 (0.88%)
Ex-Dividend Date	Jul 17, 2026

Volume	717
Open	1,106.00
Previous Close	1,104.30
Day's Range	1,089.95 - 1,112.25
52-Week Range	737.00 - 1,255.00
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment i...

• Industry: Pharmaceutical Preparations
• Founded: 1928
• Employees: 1,384
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507747

Financial Performance

In fiscal year 2026, TTK Healthcare's revenue was 8.57 billion, an increase of 6.96% compared to the previous year's 8.01 billion. Earnings were 656.81 million, a decrease of -19.57%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 5, 2026

Data Sources Report a data error